127 related articles for article (PubMed ID: 3015472)
1. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study.
Park CH; Suh JH; Yoo HS; Lee JT; Kim DI
Clin Nucl Med; 1986 Jul; 11(7):514-7. PubMed ID: 3015472
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.
Madsen MT; Park CH; Thakur ML
J Nucl Med; 1988 Jun; 29(6):1038-44. PubMed ID: 2836572
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
Ohishi H; Uchida H; Yoshimura H; Ohue S; Ueda J; Katsuragi M; Matsuo N; Hosogi Y
Radiology; 1985 Jan; 154(1):25-9. PubMed ID: 2981114
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings.
Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Madsen MT
Cancer Chemother Pharmacol; 1989; 23 Suppl():S54-8. PubMed ID: 2538267
[TBL] [Abstract][Full Text] [Related]
7. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
8. 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer.
Yu J; Häfeli UO; Sands M; Dong Y
Appl Radiat Isot; 2003 May; 58(5):567-73. PubMed ID: 12735973
[TBL] [Abstract][Full Text] [Related]
9. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
10. Intraarterial HCC therapy with I-131-Lipiodol.
Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
[TBL] [Abstract][Full Text] [Related]
11. [Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].
Raoul JL; Duvauferrier R; Bourguet P; Bretagne JF; Coornaert S; Darnault P; Deugnier Y; Herry JY; Gastard J
J Radiol; 1986 Nov; 67(11):797-801. PubMed ID: 3027321
[TBL] [Abstract][Full Text] [Related]
12. Development of Semiautomated Module for Preparation of
Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A
Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645
[TBL] [Abstract][Full Text] [Related]
13. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma.
Raoul JL; Duvauferrier R; Bretagne JF; Bourguet P; Heresbach D; Siproudhis L; Gosselin M
Scand J Gastroenterol; 1993 Mar; 28(3):217-23. PubMed ID: 7680489
[TBL] [Abstract][Full Text] [Related]
15. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma detected by iodized oil.
Yumoto Y; Jinno K; Tokuyama K; Araki Y; Ishimitsu T; Maeda H; Konno T; Iwamoto S; Ohnishi K; Okuda K
Radiology; 1985 Jan; 154(1):19-24. PubMed ID: 2981112
[TBL] [Abstract][Full Text] [Related]
18. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.
Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS
Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473
[TBL] [Abstract][Full Text] [Related]
19. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
[No Abstract] [Full Text] [Related]
20. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
Shinto AS; Karuppusamy KK; Kurup RER; Pandiyan A; Jayaraj AV
Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
